Boris Engels

Title: The Innovative Contributions of Boris Engels

Introduction

Boris Engels is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of cancer research through his innovative work on chimeric antigen receptors. His research focuses on developing binding proteins that target cancer-specific glycopeptide variants, which can lead to advancements in cancer treatment.

Latest Patents

Boris Engels holds a patent for "Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants." This patent discloses binding proteins that specifically bind to a cancer-specific glycosylation variant of a protein. The invention also includes polynucleotides encoding these binding proteins, which can be used to treat, prevent, or ameliorate symptoms of diseases such as cancer. He has 1 patent to his name.

Career Highlights

Engels is affiliated with The University of Chicago, where he conducts his research and contributes to the academic community. His work is pivotal in the ongoing fight against cancer, showcasing his dedication to improving patient outcomes through innovative scientific solutions.

Collaborations

Boris Engels collaborates with esteemed colleagues such as Hans Schreiber and Christian Idel. These partnerships enhance the research efforts and broaden the impact of their findings in the field of cancer treatment.

Conclusion

Boris Engels exemplifies the spirit of innovation in the realm of medical research. His contributions, particularly in the development of targeted therapies for cancer, highlight the importance of scientific advancements in improving healthcare.